These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23060098)

  • 41. Identification and characterization of three inherited genomic copy number variations associated with familial schizophrenia.
    Liao HM; Chao YL; Huang AL; Cheng MC; Chen YJ; Lee KF; Fang JS; Hsu CH; Chen CH
    Schizophr Res; 2012 Aug; 139(1-3):229-36. PubMed ID: 22682706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population of African descent.
    Emeville E; Broquère C; Brureau L; Ferdinand S; Blanchet P; Multigner L; Romana M
    PLoS One; 2014; 9(9):e107275. PubMed ID: 25198353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
    Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
    Oakley-Girvan I; Feldman D; Eccleshall TR; Gallagher RP; Wu AH; Kolonel LN; Halpern J; Balise RR; West DW; Paffenbarger RS; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1325-30. PubMed ID: 15298953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
    Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rare de novo germline copy-number variation in testicular cancer.
    Stadler ZK; Esposito D; Shah S; Vijai J; Yamrom B; Levy D; Lee YH; Kendall J; Leotta A; Ronemus M; Hansen N; Sarrel K; Rau-Murthy R; Schrader K; Kauff N; Klein RJ; Lipkin SM; Murali R; Robson M; Sheinfeld J; Feldman D; Bosl G; Norton L; Wigler M; Offit K
    Am J Hum Genet; 2012 Aug; 91(2):379-83. PubMed ID: 22863192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
    Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Hu JJ; Sterling D; Lange EM; Hawkins GA; Turner A; Ewing CM; Faith DA; Johnson JR; Suzuki H; Bujnovszky P; Wiley KE; DeMarzo AM; Bova GS; Chang B; Hall MC; McCullough DL; Partin AW; Kassabian VS; Carpten JD; Bailey-Wilson JE; Trent JM; Ohar J; Bleecker ER; Walsh PC; Isaacs WB; Meyers DA
    Nat Genet; 2002 Oct; 32(2):321-5. PubMed ID: 12244320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of germline copy number variation in susceptibility of human diseases.
    Hu L; Yao X; Huang H; Guo Z; Cheng X; Xu Y; Shen Y; Xu B; Li D
    J Genet Genomics; 2018 Jan; 45(1):3-12. PubMed ID: 29396143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
    Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
    Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. African-American heredity prostate cancer study: a model for genetic research.
    Powell IJ; Carpten J; Dunston G; Kittles R; Bennett J; Hoke G; Pettaway C; Weinrich S; Vijayakumar S; Ahaghotu CA; Boykin W; Mason T; Royal C; Baffoe-Bonnie A; Bailey-Wilson J; Berg K; Trent J; Collins F
    J Natl Med Assoc; 2001 Apr; 93(4):120-3. PubMed ID: 12653398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
    Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.
    Schaid DJ; McDonnell SK; Zarfas KE; Cunningham JM; Hebbring S; Thibodeau SN; Eeles RA; Easton DF; Foulkes WD; Simard J; Giles GG; Hopper JL; Mahle L; Moller P; Badzioch M; Bishop DT; Evans C; Edwards S; Meitz J; Bullock S; Hope Q; Guy M; Hsieh CL; Halpern J; Balise RR; Oakley-Girvan I; Whittemore AS; Xu J; Dimitrov L; Chang BL; Adams TS; Turner AR; Meyers DA; Friedrichsen DM; Deutsch K; Kolb S; Janer M; Hood L; Ostrander EA; Stanford JL; Ewing CM; Gielzak M; Isaacs SD; Walsh PC; Wiley KE; Isaacs WB; Lange EM; Ho LA; Beebe-Dimmer JL; Wood DP; Cooney KA; Seminara D; Ikonen T; Baffoe-Bonnie A; Fredriksson H; Matikainen MP; Tammela TL; Bailey-Wilson J; Schleutker J; Maier C; Herkommer K; Hoegel JJ; Vogel W; Paiss T; Wiklund F; Emanuelsson M; Stenman E; Jonsson BA; Grönberg H; Camp NJ; Farnham J; Cannon-Albright LA; Catalona WJ; Suarez BK; Roehl KA
    Hum Genet; 2006 Nov; 120(4):471-85. PubMed ID: 16932970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.
    Powell IJ
    Arch Esp Urol; 2011 Oct; 64(8):711-9. PubMed ID: 22052754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethnic differences in prostate cancer.
    Kheirandish P; Chinegwundoh F
    Br J Cancer; 2011 Aug; 105(4):481-5. PubMed ID: 21829203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.
    Shlien A; Tabori U; Marshall CR; Pienkowska M; Feuk L; Novokmet A; Nanda S; Druker H; Scherer SW; Malkin D
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11264-9. PubMed ID: 18685109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
    Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
    J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
    Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.
    Cooney KA; McCarthy JD; Lange E; Huang L; Miesfeldt S; Montie JE; Oesterling JE; Sandler HM; Lange K
    J Natl Cancer Inst; 1997 Jul; 89(13):955-9. PubMed ID: 9214675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.